SEC charges Theranos and CEO Elizabeth Holmes with ‘massive fraud’

In a statement, the commission said that the company, and its two executives, misled investors about the capability of its blood testing technology. Theranos’ big selling point was that its hardware could scan for a number of diseases with just a small drop of blood. Unfortunately, the company was never able to demonstrate that its …

Continue reading “SEC charges Theranos and CEO Elizabeth Holmes with ‘massive fraud’”